Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced it filed its annual report on Form 20-F for the fiscal year ...

Add Yahoo as a preferred source to see more of our stories on Google. People who were originally fully vaccinated with the Chinese-made Sinovac COVID-19 vaccine were shown to develop a high degree of ...

Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A medical worker holds a dose of the Sinovac vaccine at a district health facility as Indonesia begins mass ...

View Sinovac Biotech Ltd. SVA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that a special dividend of US$55.00 per common share, as ...

The Government of Mexico City has decided to increase the rate of vaccination in the city, given that the Delta variant of SARSCov2 has again accelerated the infection and the Capotalinos hospitals ...

China’s Sinovac claimed that a third dose of its Covid-19 vaccine is 94% effective against the omicron variant of the coronavirus, Nikkei Asia reported, in a statement the comes just a day after a ...

BEIJING (Reuters) - Sinovac Biotech's COVID-19 vaccine appears to be safe and able to trigger immune responses among children and adolescents, according to preliminary results from early and mid-stage ...

A study of a small Brazilian town vaccinated with the shot made by Sinovac Biotech Ltd. showed it can control Covid-19 outbreaks more effectively than expected from clinical testing, giving another ...